CVSGL Stock Financial Analysis - CVS Group plc (BATS-CHIXE) Stock

CVS Group plc
GB ˙ BATS-CHIXE ˙ GB00B2863827
Overview
CVS Group plc, based in the UK, operates primarily in the veterinary services industry, providing an extensive range of services and products to the veterinary market. Established in 1999, the company has grown significantly both organically and through acquisitions, expanding its network of veterinary practices, diagnostic laboratories, pet crematoria, and e-commerce platforms. A key focus for CVS Group is the enhancement of clinical practice through the introduction of advanced veterinary technology and specialist referral services, aiming to improve standards of care across its operations. Additionally, the company is active in education and training for veterinary professionals, emphasizing continuous improvement in veterinary science and pet health management.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
  • The revenue for CVS Group plc as of 31 December 2024 is 668.60 MM.
  • The operating income for CVS Group plc as of 31 December 2024 is 45.60 MM.
  • The net income for CVS Group plc as of 31 December 2024 is 2.80 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2024-12-31 668.60 45.60 2.80
2024-09-30 657.95 48.20 4.50
2024-06-30 647.30 50.80 6.20
2023-12-31 613.10 68.50 35.40
2023-09-30 601.00 68.45 38.65
2023-06-30 588.90 68.40 41.90
2023-03-31 592.55 55.15 35.60
2022-12-31 576.80 48.00 29.30
2022-09-30 565.50 45.40 27.50
2022-06-30 554.20 42.80 25.70
2022-03-31 546.20 45.40 25.60
2021-12-31 538.20 48.00 25.50
2021-09-30 524.15 44.05 22.40
2021-06-30 510.10 40.10 19.30
2021-03-31 479.50 32.60 15.35
2020-12-31 448.90 25.10 11.40
2020-09-30 438.35 21.80 8.55
Income Statement: EPS
  • The earnings per share basic for CVS Group plc as of 31 December 2024 is 0.04.
  • The earnings per share diluted for CVS Group plc as of 31 December 2024 is 0.04.
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2024-12-31 0.04 0.04
2024-09-30 0.06 0.06
2024-06-30 0.09 0.09
2023-12-31 0.50 0.50
2023-09-30 0.54 0.54
2023-06-30 0.59 0.58
2023-03-31 0.50 0.50
2022-12-31 0.41 0.41
2022-09-30 0.39 0.38
2022-06-30 0.36 0.36
2022-03-31 0.36 0.36
2021-12-31 0.36 0.36
2021-09-30 0.32 0.31
2021-06-30 0.27 0.27
2021-03-31 0.22 0.22
2020-12-31 0.16 0.16
2020-09-30 0.12 0.12
Cash Flow: Operations, Investing, Financing
  • The cash from operating activities for CVS Group plc as of 31 December 2024 is 66.70 MM.
  • The cash from investing activities for CVS Group plc as of 31 December 2024 is -100.40 MM.
  • The cash from financing activities for CVS Group plc as of 31 December 2024 is 13.50 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2024-12-31 66.70 -100.40 13.50
2024-09-30 67.25 -120.45 40.90
2024-06-30 67.80 -140.50 68.30
2023-12-31 88.90 -135.90 51.90
2023-09-30 86.70 -117.90 19.90
2023-06-30 84.50 -99.90 -12.10
2023-03-31 82.90 -79.30 -14.55
2022-12-31 81.30 -58.70 -17.00
2022-09-30 78.40 -51.90 -16.05
2022-06-30 75.50 -45.10 -15.10
2022-03-31 61.40 -47.15 -16.00
2021-12-31 47.30 -49.20 -16.90
2021-09-30 53.75 -42.30 -14.75
2021-06-30 60.20 -35.40 -12.60
2021-03-31 75.90 -29.00 -23.95
2020-12-31 91.60 -22.60 -35.30
2020-09-30 84.60 -21.10 -42.15
Valuation Metrics : PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2024-12-31
2024-09-30
2024-06-30
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
2024-12-31
2024-09-30
2024-06-30
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Management Effectiveness
  • The roa for CVS Group plc as of 31 December 2024 is 0.00.
  • The roe for CVS Group plc as of 31 December 2024 is 0.01.
  • The roic for CVS Group plc as of 31 December 2024 is 0.01.
  • The croic for CVS Group plc as of 31 December 2024 is -0.04.
  • The ocroic for CVS Group plc as of 31 December 2024 is 0.12.
Period End (TTM) ROA ROE ROIC CROIC OCROIC
2024-12-31 0.00 0.01 0.01 -0.04 0.12
2024-09-30 0.01 0.02 0.01 -0.02 0.12
2024-06-30 0.06 0.14 0.06 0.01 0.16
2023-12-31 0.07 0.17 0.07 -0.02 0.16
2023-09-30 0.08 0.19 0.09 -0.06 0.19
2023-06-30 0.08 0.19 0.09 -0.06 0.19
2023-03-31 0.07 0.16 0.08 -0.02 0.18
2022-12-31 0.06 0.13 0.07 0.02 0.19
2022-09-30 0.06 0.13 0.07 0.02 0.19
2022-06-30 0.05 0.13 0.06 0.04 0.19
2022-03-31 0.05 0.13 0.06 -0.00 0.15
2021-12-31 0.05 0.14 0.07 -0.05 0.12
2021-09-30 0.05 0.12 0.06 -0.01 0.14
2021-06-30 0.04 0.12 0.05 0.03 0.16
2021-03-31 0.03 0.09 0.04 0.06 0.20
2020-12-31 0.02 0.07 0.03 0.09 0.25
2020-09-30 0.02 0.05 0.02 0.06 0.23
Gross Margins
  • The gross margin for CVS Group plc as of 31 December 2024 is 0.43.
  • The net margin for CVS Group plc as of 31 December 2024 is 0.00.
  • The operating margin for CVS Group plc as of 31 December 2024 is 0.07.
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
2024-12-31 0.43 0.00 0.07
2024-09-30 0.43 0.01 0.07
2024-06-30 0.43 0.06 0.09
2023-12-31 0.43 0.06 0.10
2023-09-30 0.43 0.07 0.10
2023-06-30 0.43 0.07 0.10
2023-03-31 0.43 0.06 0.09
2022-12-31 0.43 0.05 0.08
2022-09-30 0.43 0.05 0.08
2022-06-30 0.43 0.05 0.08
2022-03-31 0.43 0.05 0.08
2021-12-31 0.43 0.05 0.09
2021-09-30 0.43 0.04 0.08
2021-06-30 0.44 0.04 0.08
2021-03-31 0.43 0.03 0.07
2020-12-31 0.43 0.03 0.06
2020-09-30 0.41 0.02 0.05
Identifiers and Descriptors
Central Index Key (CIK)
Industry Groups
Other Listings
US:CVSGF
GB:CVSG 1,226.00 GBX
DE:4C9 €13.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista